Angiodynamics (ANGO) Assets (2011 - 2026)

Angiodynamics' Assets history runs 16 years deep, the most recent figure standing at $267.2 million for Q2 2026.

• Quarterly Assets fell 4.63% year-over-year to $267.2 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $267.2 million (down 4.63% YoY) and the FY2026 annual result came in at $267.2 million, down 4.63% from the prior year.
• Assets was $267.2 million for Q2 2026 at Angiodynamics, up from $260.7 million in the prior quarter.
• Across five years, Assets topped out at $558.2 million in Q4 2022 and bottomed at $260.7 million in Q1 2026.
• A 5-year average of $396.5 million and a median of $321.3 million in 2024 frame the typical range for Assets.
• Annual changes were most pronounced in 2022 — Assets increased 0.74% — and 2024, when it slumped 41.64%.
• Angiodynamics' Assets stood at $558.2 million in 2022, then fell by 10.5% to $499.6 million in 2023, then slumped by 41.64% to $291.6 million in 2024, then decreased by 7.5% to $269.7 million in 2025, then decreased by 0.93% to $267.2 million in 2026.
• Business Quant data shows ANGO's Assets at $267.2 million in Q2 2026, $260.7 million in Q1 2026, and $269.7 million in Q4 2025.